These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Drug abuse: The doctor's role. Wolfson EA J Med Soc N J; 1970 Aug; 67(8):465-71. PubMed ID: 5269964 [No Abstract] [Full Text] [Related]
23. The mechanism of action of hallucinogenic drugs on a possible serotonin receptor in the brain. Smythies JR; Benington F; Morin RD Int Rev Neurobiol; 1970; 12():207-33. PubMed ID: 4918144 [No Abstract] [Full Text] [Related]
24. LSD and other related hallucinogens elicit myoclonic jumping behavior in the guinea pig. Carvey P; Nausieda P; Weertz R; Klawans H Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):199-210. PubMed ID: 2748860 [TBL] [Abstract][Full Text] [Related]
25. Some observations on the behavioural effects of hallucinogenic drugs on rats: potentiation by two drugs affecting monoamine metabolism. Tonge SR; Leonard BE Arch Int Pharmacodyn Ther; 1972 Jan; 195(1):168-76. PubMed ID: 5010826 [No Abstract] [Full Text] [Related]
26. Discriminable stimuli produced by hallucinogens. Kuhn DM; White FJ; Appel JB Psychopharmacol Commun; 1976; 2(4):345-8. PubMed ID: 996285 [No Abstract] [Full Text] [Related]
29. Accumulation of tritiated 5-hydroxytryptamine in brain slices. Ross SB; Renyl AL Life Sci; 1967 Jul; 6(13):1407-15. PubMed ID: 4382451 [No Abstract] [Full Text] [Related]
30. Drug-induced discrimination: a description of the paradigm and a review of its specific application to the study of hallucinogenic agents. Glennon RA; Rosecrans JA; Young R Med Res Rev; 1983; 3(3):289-340. PubMed ID: 6350763 [No Abstract] [Full Text] [Related]
31. Glycogen phosphorylase levels in the brain of rats treated with psychotomimetic drugs and with tranquilizers. Iriye TT; Kuna A; Simmonds FA Biochem Pharmacol; 1965 Jul; 14(7):1169-71. PubMed ID: 5892600 [No Abstract] [Full Text] [Related]
32. Spectrum analysis of EEG changes induced by psychotomimetic agents. Eidelberg E; Long M; Miller MK Int J Neuropharmacol; 1965 Sep; 4(5):255-64. PubMed ID: 5865229 [No Abstract] [Full Text] [Related]
33. Inhibition of isolation-induced attack behavior of mice by drugs. Uyeno ET J Pharm Sci; 1966 Feb; 55(2):215-6. PubMed ID: 5923276 [No Abstract] [Full Text] [Related]
34. Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'. Koerner J; Appel JB Psychopharmacology (Berl); 1982; 76(2):130-5. PubMed ID: 6805022 [TBL] [Abstract][Full Text] [Related]
35. Lysergic acid diethylamide (LSD) as a discriminative cue: drugs with similar stimulus properties. Schechter MD; Rosecrans JA Psychopharmacologia; 1972; 26(3):313-6. PubMed ID: 5073050 [No Abstract] [Full Text] [Related]
38. Contractile responses of guinea pig umbilical arteries to various hallucinogenic agents. Nair X Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):535-42. PubMed ID: 4445570 [No Abstract] [Full Text] [Related]
39. The hallucinogens and the inhalants. Cohen S Psychiatr Clin North Am; 1984 Dec; 7(4):681-8. PubMed ID: 6097885 [TBL] [Abstract][Full Text] [Related]
40. Hallucinogens potentiate responses to serotonin and norepinephrine in the facial motor nucleus. McCall RB; Aghajanian GK Life Sci; 1980 Apr; 26(14):1149-56. PubMed ID: 7392793 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]